Angiex

Angiex is developing first‑in‑class Nuclear‑Delivered Antibody‑Drug Conjugates™ (ND‑ADCs) to address cancer lethality. The company aims to make cancer a non‑lethal disease, leveraging novel biology to deliver safe and effective therapies. Over one‑third of people in developed countries develop cancer, with 10 million deaths annually; Angiex’s vision is that no one should die of cancer.

Angiex is profiled on the APIs.io network. Tagged areas include Biotechnology, Oncology, Drug Development, Antibody-Drug Conjugates, and Cancer Therapy.

Angiex’s developer surface includes documentation, engineering blog, and 5 more developer resources.

🌐 Visit website 📡 Profile data on GitHub

8.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-10-23 · rubric v0.25.0 · Show this score on your site →

0 APIs

Biotechnology Oncology Drug Development Antibody-Drug Conjugates Cancer Therapy Company

Kin Score

Kin Score How this is scored →
scored 2026-10-23 · rubric v0.25.0

Composite quality — 8.7/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 2.0 / 17

Access Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.5 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Pagination 5 / 5

Distinct Operations 3 / 3

Regulatory Posture applies to this provider. Its tags matched the Horizontal (data, software, accessibility, platform) regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Show this score on your site.

It updates itself when the score changes. Paste this where you link to your API docs:

<a href="https://apis.io/providers/angiex/"><img src="https://apis.io/badge/angiex/card.svg" alt="Angiex on APIs.io — Kin Score by API Evangelist"></a>

Other styles, a README pill and a shields.io endpoint are on the badge page.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/angiex: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Angiex Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Documentation 1

Reference material describing how the API behaves

Documentation

Documentation

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 3

The organization behind the API

Newsroom

Newsroom

Blog

Blog

Website

Website

Other 1

Properties that don't map to a standard resource type

Hosts

Hosts

Source (apis.yml)

aid: angiex
name: Angiex
image: https://angiex.com/ASSETS/IMG/news/_1200x630_crop_center-center_none/news-default.png
description: Angiex is developing first‑in‑class Nuclear‑Delivered Antibody‑Drug Conjugates™ (ND‑ADCs) to address cancer lethality.
  The company aims to make cancer a non‑lethal disease, leveraging novel biology to deliver safe and effective therapies.
  Over one‑third of people in developed countries develop cancer, with 10 million deaths annually; Angiex’s vision is that
  no one should die of cancer.
url: https://raw.githubusercontent.com/api-evangelist/angiex/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-09-24 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-09-24'
modified: '2026-09-24'
tags:
- Biotechnology
- Oncology
- Drug Development
- Antibody-Drug Conjugates
- Cancer Therapy
- Company
tags_raw:
- Biotechnology
- Oncology
- Drug Development
- Antibody‑Drug Conjugates
- Cancer Therapy
- Company
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Hosts
  url: hosts/angiex-hosts.yml
- type: PrivacyPolicy
  url: https://angiex.com/privacy-policy/
- type: Newsroom
  url: https://angiex.com/news
- type: Documentation
  url: https://angiex.com/ASSETS/DOCS/Angiex-World_ADC_POSTER_Final.pdf
- type: Blog
  url: https://angiex.com/blog
- type: DomainSecurity
  url: security/angiex-domain-security.yml
- type: Website
  url: https://angiex.com/
apis: []
x-coverage:
  state: none
  reason: no-developer-program
  detail: Angiex provides only corporate website and PDF poster with no developer program or API documentation.
  evidence:
  - url: https://angiex.com/ASSETS/DOCS/Angiex-World_ADC_POSTER_Final.pdf
    status: 200
  checked: 2026-09-24
x-enrichment:
  date: '2026-09-24'
  status: enriched
  artifacts_added: 5
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/angiex"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/angiex/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/angiex/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.